Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Advantage Alpha Capital Partners LP

Advantage Alpha Capital Partners LP trimmed its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 38.8% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,139 shares of the biotechnology company’s stock after selling 3,255 shares during the period. Advantage Alpha Capital Partners LP’s holdings in Axon Enterprise were worth $2,054,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of AXON. CIBC Asset Management Inc boosted its position in shares of Axon Enterprise by 9.2% during the third quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock worth $4,227,000 after buying an additional 895 shares during the period. Foundations Investment Advisors LLC acquired a new position in Axon Enterprise during the 3rd quarter worth $221,000. Sequoia Financial Advisors LLC grew its stake in shares of Axon Enterprise by 4.9% in the third quarter. Sequoia Financial Advisors LLC now owns 1,727 shares of the biotechnology company’s stock worth $690,000 after purchasing an additional 81 shares in the last quarter. Axxcess Wealth Management LLC acquired a new position in shares of Axon Enterprise during the third quarter valued at $814,000. Finally, Jag Capital Management LLC raised its stake in shares of Axon Enterprise by 9.7% during the third quarter. Jag Capital Management LLC now owns 56,086 shares of the biotechnology company’s stock valued at $22,412,000 after purchasing an additional 4,954 shares in the last quarter. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Trading Down 2.8 %

Shares of NASDAQ AXON opened at $619.00 on Tuesday. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 12 month low of $224.28 and a 12 month high of $641.20. The company has a market cap of $47.20 billion, a price-to-earnings ratio of 159.95, a P/E/G ratio of 14.02 and a beta of 0.94. The business has a fifty day simple moving average of $468.24 and a 200-day simple moving average of $370.65.

Insider Buying and Selling at Axon Enterprise

In other news, President Joshua Isner sold 20,000 shares of Axon Enterprise stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the transaction, the president now owns 208,166 shares in the company, valued at approximately $126,179,820.90. The trade was a 8.77 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Patrick W. Smith sold 75,000 shares of the company’s stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $356.53, for a total value of $26,739,750.00. Following the transaction, the chief executive officer now directly owns 2,970,366 shares in the company, valued at $1,059,024,589.98. The trade was a 2.46 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 260,256 shares of company stock valued at $105,984,120. 5.70% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on AXON shares. Barclays increased their target price on shares of Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a research report on Wednesday, August 7th. Robert W. Baird raised their price objective on shares of Axon Enterprise from $440.00 to $460.00 and gave the company an “outperform” rating in a research note on Monday, November 4th. Northland Securities upped their target price on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research report on Monday, November 11th. JMP Securities lifted their price target on Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research report on Thursday, October 31st. Finally, Craig Hallum upped their price objective on Axon Enterprise from $370.00 to $376.00 and gave the company a “buy” rating in a report on Wednesday, August 7th. Two investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $427.83.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.